Literature DB >> 3202471

Asbestos-induced endothelial cell activation and injury. Demonstration of fiber phagocytosis and oxidant-dependent toxicity.

J G Garcia1, L D Gray, R F Dodson, K S Callahan.   

Abstract

Vascular endothelial cell injury is important in the development of a variety of chronic interstitial lung disorders. However, the involvement of such injury in the inflammatory response associated with the inhalation of asbestos fibers is unclear and the mechanism of asbestos fiber cytotoxicity remains unknown. In the present study, human umbilical vein endothelial cells were challenged with amosite asbestos and several parameters of cellular function were examined. Electron microscopic examination revealed that endothelial cell exposure to asbestos resulted in active phagocytosis of these particulates. Biochemical evidence of dose-dependent asbestos-mediated endothelial cell activation was indicated by increased metabolism of arachidonic acid. For example, amosite asbestos (500 micrograms/ml) produced a ninefold increase in prostacyclin (PGI2) levels over those levels in non-exposed cells. Incubation of human endothelial cells with asbestos fibers induced specific 51Cr release in both a dose- and time-dependent fashion indicative of cellular injury. Injury induced by amosite asbestos was not significantly attenuated by treatment of the endothelial cell monolayer with either the iron chelator deferoxamine, which prevents hydroxyl radical (.OH) formation, or by the superoxide anion (O2-) scavenger, superoxide dismutase. However, significant dose-dependent protection was observed with the hydrogen peroxide (H2O2) scavenger, catalase. Chelation of elemental iron present within amosite asbestos fibers by deferoxamine produced a 33% reduction in asbestos cytotoxicity, suggesting a potential role for hydroxyl radical-mediated injury via the iron-catalyzed Haber-Weiss reaction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202471     DOI: 10.1164/ajrccm/138.4.958

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

Review 1.  The molecular basis of asbestos induced lung injury.

Authors:  D W Kamp; S A Weitzman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

2.  Conversion of cultured monocytes/macrophages into endothelial-like cells through direct contact with endothelial cells.

Authors:  Miyako Bohgaki; Hiromichi Kitaguchi
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

3.  Crocidolite induces prostaglandin I(2) release mediated by vitronectin receptor and cyclooxygenase-2 in lung cells.

Authors:  Francisco J Leyva; Kevan Roberts
Journal:  Lung       Date:  2010-02-13       Impact factor: 2.584

4.  Pulmonary hypertension induced by amosite asbestos: a physiological and morphologic study in the guinea pig.

Authors:  J Wright; B Wiggs; A Churg
Journal:  Lung       Date:  1991       Impact factor: 2.584

5.  Bacillus Calmette-Guérin (BCG) and immunoglobulins synergistically enhance mineral dust-induced production of reactive oxygen metabolites by human monocytes.

Authors:  P Nyberg; M Klockars
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

6.  Biphasic lung diffusing capacity: detection of early asbestos induced changes in lung function.

Authors:  Z Dujić; J Tocilj; S Boschi; M Sarić; D Eterović
Journal:  Br J Ind Med       Date:  1992-04

7.  Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5.

Authors:  A M Boylan; D A Sanan; D Sheppard; V C Broaddus
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

8.  Increased focal adhesion kinase- and urokinase-type plasminogen activator receptor-associated cell signaling in endothelial cells exposed to asbestos.

Authors:  A Barchowsky; B M Lannon; L C Elmore; M D Treadwell
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.